A Complete Response After Pseudo-progression: Pembrolizumab for Metastatic Squamous Cell Carcinoma (SCC) of the Bladder

被引：5
|
作者：
Kao, Chester [1 ]
McNamara, Megan [1 ,2 ,3 ]
Alley, Chris [4 ]
Spector, Neil [1 ,2 ,3 ]
Jauhari, Shekeab [1 ]
Gupta, Rajan T. [5 ]
Zhang, Tian [1 ,2 ]
Zhu, Jason [1 ]
机构：
[1] Duke Univ, Dept Med, Durham, NC USA
[2] Duke Univ, Duke Canc Inst, Durham, NC USA
[3] Durham VA Med Ctr, Dept Hematol & Oncol, Durham, NC USA
[4] Duke Univ, Dept Pathol, Durham, NC 27706 USA
[5] Duke Univ, Dept Radiol, Durham, NC 27710 USA
来源：
CLINICAL GENITOURINARY CANCER | 2019年 / 17卷 / 03期
关键词：
Bladder cancer; Cisplatin ineligible; Immune checkpoint inhibitors; Metastatic bladder squamous cell carcinoma; PD-1; inhibitor; Psuedoprogression; IMMUNE-RELATED RESPONSE; RADICAL CYSTECTOMY; CISPLATIN; SURVIVAL; THERAPY; PSEUDOPROGRESSION; METHOTREXATE; VINBLASTINE; DOXORUBICIN; OUTCOMES;
D O I：
10.1016/j.clgc.2019.03.019
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：E672 / E677
页数：6
相关论文
共 50 条
  • [1] Pathological complete response to neoadjuvant pembrolizumab in a patient with metastatic cutaneous squamous cell carcinoma
    Blaise, Manon
    Poissonnet, Gilles
    Cardot-Leccia, Nathalie
    Sudaka, Anne
    Velin, Marine
    Chassang, Madleen
    Razzouk-Cadet, Micheline
    Picard-Gauci, Alexandra
    Passeron, Thierry
    Montaudie, Henri
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2023, 37 (11) : E1318 - E1320
  • [2] Complete Tumor Response of Tracheal Squamous Cell Carcinoma After Treatment With Pembrolizumab
    Maller, Bradley
    Kaszuba, Frank
    Tanvetyanon, Tawee
    ANNALS OF THORACIC SURGERY, 2019, 107 (04): : E273 - E274
  • [3] Acase report of pseudo-progression after pembrolizumab in metastatic gastric cancer and areview of immunotherapy in gastroesophageal tumors
    Taghizadeh, Hossein
    Lampichler, Katharina
    Beer, Andrea
    Preusser, Matthias
    Ilhan-Mutlu, Aysegul
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2019, 12 (01) : 51 - 59
  • [4] A case report of pseudo-progression after pembrolizumab in metastatic gastric cancer and a review of immunotherapy in gastroesophageal tumors
    Hossein Taghizadeh
    Katharina Lampichler
    Andrea Beer
    Matthias Preusser
    Aysegul Ilhan-Mutlu
    memo - Magazine of European Medical Oncology, 2019, 12 : 51 - 59
  • [5] Complete Remission of ossar metastatic Squamous Cell Carcinoma under Pembrolizumab
    Pietschke, K.
    Lomberg, D.
    Koechel, A.
    Mueller, A.
    Eigentler, T.
    Leiter-Stoeppke, U.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2018, 16 : 73 - 73
  • [6] Complete response of metastatic Merkel cell carcinoma under treatment with Pembrolizumab
    Koechel, A.
    Wilhelmi, J.
    Garbe, C.
    Eigentler, T.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2017, 15 : 79 - 80
  • [7] Tumor response like pseudo-progression to lenvatinib in advanced thymic carcinoma
    Ito, Koki
    Yamaguchi, Ou
    Kaira, Kyoichi
    Imai, Hisao
    Kagamu, Hiroshi
    LUNG CANCER, 2023, 179
  • [8] Symptomatic Pleural Restriction Due to Pseudo-Progression of Unknown Metastatic Breast Cancer in a Patient Treated with Pembrolizumab
    Stroh, G.
    Markovic, S.
    Peikert, T.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [9] Dramatic response of refractory metastatic squamous cell carcinoma of the skin with cetuximab/pembrolizumab
    Hober, Candice
    Jamme, Philippe
    Desmedt, Eve
    Greliak, Anna
    Mortier, Laurent
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2021, 13
  • [10] Pathologic complete response with pembrolizumab plus axitinib in metastatic renal cell carcinoma
    Kazuki Shimizu
    Satoshi Tamada
    Yudai Matsuoka
    Ishun Go
    Satoshi Okumura
    Masao Ogawa
    Tetsuji Ohmachi
    International Cancer Conference Journal, 2022, 11 : 205 - 209
12345